Integrating Systematic Data of Geriatric Medicine to Explore the Solution for Health Aging

NCT ID: NCT04207502

Last Updated: 2019-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-01

Study Completion Date

2020-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to build up the comprehensive database of geriatric medicine for local Taiwanese.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project is the pilot for the basis of establishing the schema of database and efficient procedures including subject recruitment, specimen collection, management, and measurement of samples obtained from multiple sources. We will focus on deciphering the correlation of sleep quality and the integrity of brain structure by integrating the holistic health data, socio-demographic characteristics, MRI, wearable technique, and laboratory technology including clinical lab, genotyping, metabolomics, gut microbiome, to unravel the clinical feature of which the age will effect on the frequency of sleep disturbance. This project will not only systematically study the aging effect on the sleep quality and brain structure integrity, but pave the way for exploring a variety of aging-related indications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disturbance Cognitive Change Aging

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

dementia depression brain structure system biology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants of annual health checkup conducted by either Taipei city or Chang Gung Health and Culture Village.
* aged ≧ 60 years old.
* have medical record in Chang Gung Memorial Hospital.
* resided in the Taiwan area over 180 days in past one year.

Exclusion Criteria

* Participants with the medical history of severe organ disorders, severe autoimmune disease, or cancer under treatment.
* Contraindications or previously failure for receiving brain computerized tomography or magnetic resonance imaging scan.
* Participants who had receive outpatient clinic follow-ups with diseases that may affect the cognitive evaluation or presentation.
* Depression with ongoing diagnosis and treatment, suicide idea or suicide behavior in the past 6 months.
* Difficulty in communication or disabilities
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chang Gung University

OTHER

Sponsor Role collaborator

Chang Gung Memorial Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

JI-TSENG FANG, M.D.

Role: STUDY_CHAIR

Chang Gung Memorial Hospital

NING-HUNG CHEN, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

GENG-HAO LIU, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

JUNG LUNG HSU, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

SHWU-HUA LEE, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

CHIH-MING LIN, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

CHUNG-HAO LIN, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

CHENG HONG TOH, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

CHENG-HSUN CHIU, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung Memorial Hospital

MEI-LING CHENG, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Chang Gung University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taipei Chang Gung Memorial Hospital

Taipei, , Taiwan

Site Status RECRUITING

Chang Gung Health and Culture Village

Taoyuan, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

JI-TSENG FANG, M.D.

Role: CONTACT

Phone: +886-3-3281200

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

CHUNG-HAO LIN, M.D.

Role: primary

CHIH-MING LIN, M.D.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

201900702A3

Identifier Type: OTHER

Identifier Source: secondary_id

CORPG3J0371

Identifier Type: -

Identifier Source: org_study_id